RTX Stock Is Soaring 5.8% — I’ve Spent 30 Years in Industrial Investing, and It’s Not the Win You Think

Posted on by

(SeaPRwire) –   By: Robert Kensington
RTX’s 5.8% premarket jump as of 6:21 a.m. ET on July 23, 2026, looks like a clear industrial earnings win at first glance. I’ve sat through hundreds of aerospace and defense earnings calls over 30 years in real-economy investing, and this one checks all the surface-level boxes. Non-GAAP EPS beats Wall Street estimates by 23 cents. Quarterly revenue blows past consensus by $1.82 billion, with 16% organic growth. Full-year guidance gets a sharp hike across the board. Most retail investors will see the headlines and hit buy before digging into the fine print. That’s a costly mistake. The market is pricing in flawless execution on a $289 billion backlog, with zero room for supply chain snags or capacity delays. Insiders aren’t buying the hype, either. They’ve sold roughly $43.86 million in stock over the past 12 months, with not a single insider buy recorded in the same window. That’s a massive red flag most people will gloss over in their rush to catch the upside. The stock’s current P/E ratio of 36.56 sits well above its historical median of 27.4. GuruFocus even flags it as significantly overvalued on its GF Value model. The company’s market cap sits at roughly $262.44 billion, enough to buy out most of its mid-tier competitors twice over. For a company that relies on long-cycle, capital-intensive production, that valuation premium is risky.

The official earnings release leads with the headline numbers, and they’re strong on paper. Q2 non-GAAP EPS came in at $1.89, 23 cents above the $1.66 Wall Street estimate. Revenue hit $24.7 billion, up 14.5% year-over-year and $1.82 billion ahead of consensus. Full-year EPS guidance jumps to $7.10–$7.25, up from the prior $6.70–$6.90 range and well above the $6.92 analyst consensus. Revenue guidance lifts to $95–$96 billion, with organic sales growth now pegged at 8–9% instead of the previous 5–6%. CEO Chris Calio frames this as a testament to strong demand and the company’s strategic positioning. He says RTX is “exceptionally well positioned to drive continued growth” as it works through its backlog, expands capacity, and brings new technologies to customers. The unspoken subtext here is far more tactical. RTX is deliberately guiding high to lock in investor confidence as it ramps up capacity spending. Higher share prices make it cheaper to raise capital for factory expansions and equipment upgrades. The raised guidance also sends a signal to customers: we have the scale and stability to deliver on large, long-term contracts. Smaller aerospace and defense players can’t match that level of guidance certainty, so they’ll lose out on bids for big commercial and defense programs. RTX isn’t just reporting good results — it’s using those results to widen the moat between itself and the rest of the field.

The official release highlights the $289 billion backlog as proof of a long, stable revenue runway ahead. The number is up 22% year-over-year, split between $170 billion in commercial orders and $119 billion in defense work. Free cash flow for the quarter hit $2.9 billion, with operating cash flow at $3.5 billion. The company’s Piotroski F-Score of 8 points to a healthy financial position. Its GF Score lands at 84 out of 100, with a Growth Rank of 8/10 and a Profitability Rank of 7/10. The market takes all this as a sign of guaranteed growth for years to come. The real story behind the backlog is more nuanced. RTX is deliberately tilting its order mix toward commercial aerospace, which now makes up 59% of the total backlog. This shift reduces its exposure to defense budget fluctuations and political gridlock in Washington. The massive backlog also gives RTX unprecedented leverage with its supply base. It can lock in multi-year material and component contracts at lower rates than smaller competitors, who don’t have the order volume to negotiate the same terms. The modest hike to free cash flow guidance tells another story. Full-year FCF guidance only moved up to $8.50–$8.75 billion from $8.25–$8.75 billion, even as revenue and EPS guidance jumped sharply. That means most of the incremental revenue from the backlog will go toward funding capacity expansion in the near term, not padding bottom-line cash returns. Investors who expect immediate cash windfalls will be disappointed. The company is investing for market share gains, not short-term shareholder payouts.

Over the next 18 months, RTX will use its backlog and elevated stock price to snap up smaller tier-2 aerospace suppliers and lock in exclusive long-term contracts with major airlines and defense agencies. Competitors with smaller order books and weaker balance sheets won’t be able to match its capital spending pace or pricing power. The stock’s current valuation premium will hold only if RTX hits every delivery milestone on its backlog without a single major supply chain disruption. If it misses even one quarter’s delivery targets, the P/E ratio will contract fast, and the 5.8% premarket gain will look like a tiny blip. For investors, the smart play isn’t chasing the surge — it’s waiting for a pullback after the first execution misstep, then buying in at a price that actually reflects the risks of long-cycle industrial production.

Author bio: Robert Kensington, a 30-year veteran of real-economy industrial investment with deep expertise in aerospace and defense market strategy.